New England Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

New England Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$197K	Sell	1,928 -11,408	-86%	-$1.11M	0.07%	276
2014 Q3	$1.22M	Buy	13,336 +7,701	+137%	+$668K	0.43%	52
2014 Q2	$464K	Sell	5,635 -50	-0.9%	-$3.82K	0.16%	169
2014 Q1	$436K	Buy	5,685 +253	+5%	+$19.7K	0.17%	151
2013 Q4	$376K	Sell	5,432 -1,571	-22%	-$103K	0.16%	171
2013 Q3	$454K	Buy	7,003 +2,200	+46%	+$139K	0.23%	116
2013 Q2	$279K	Buy	+4,803	New	+$274K	0.19%	129

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

New England Securities's FBT Position: Q4 2014 in Review

New England Securities reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 86% in Q4 2014, selling an estimated $1.11M and leaving 1,928 shares worth $197K. The position accounts for 0.07% of the portfolio, ranked #276.

New England Securities first reported a position in FBT in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.22M in Q3 2014. 112 funds tracked by Wall St. Rank hold FBT as of Q4 2014.

New England Securities held 1,928 shares of First Trust NYSE Arca Biotechnology Index Fund worth $197K as of Q4 2014.
New England Securities sold 11,408 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2014, an estimated $1.11M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.07% of New England Securities's portfolio in Q4 2014, its #276 holding.
New England Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 7 quarters since.
New England Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.22M in Q3 2014.
112 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.